Figure 1.
Figure 1. Kaplan Meier curves showing relapse-free survival after rituximab for patients with warm and cold antibody AIHA. The median time to relapse was 8.5 months for warm and 55.2 months for cold AIHA (p=0.044).

Kaplan Meier curves showing relapse-free survival after rituximab for patients with warm and cold antibody AIHA. The median time to relapse was 8.5 months for warm and 55.2 months for cold AIHA (p=0.044).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal